[1]李明明,赵 芳,张亚青.TCT、HPV联合阴道镜检测在早期宫颈癌及癌前病变筛查中的应用价值[J].医学信息,2023,36(13):103-106.[doi:10.3969/j.issn.1006-1959.2023.13.020]
　LI Ming-ming,ZHAO Fang,ZHANG Ya-qing.Application Value of TCT, HPV Combined with Colposcopy in the Screening of Early-stage Cervical Cancer and Precancerous Lesions[J].Journal of Medical Information,2023,36(13):103-106.[doi:10.3969/j.issn.1006-1959.2023.13.020]
点击复制

TCT、HPV联合阴道镜检测在早期宫颈癌及癌前病变筛查中的应用价值()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
36卷
期数:
2023年13期
页码:
103-106
栏目:
论著
出版日期:
2023-07-01

文章信息/Info

Title:
Application Value of TCT, HPV Combined with Colposcopy in the Screening of Early-stage Cervical Cancer and Precancerous Lesions
文章编号:
1006-1959（2023）13-0103-04
作者:
李明明; 赵 芳; 张亚青
（北京市门头沟区妇幼保健院体检中心，北京 102300）
Author(s):
LI Ming-ming; ZHAO Fang; ZHANG Ya-qing
(Physical Examination Center,Beijing Mentougou District Maternal and Child Health Hospital,Beijing 102300,China)
关键词:
TCT; HPV; 阴道镜; 早期宫颈癌; 癌前病变
Keywords:
TCT; HPV; Colposcopy; Early-stage cervical cancer; Precancerous lesions
分类号:
R737.33；R730.43
DOI:
10.3969/j.issn.1006-1959.2023.13.020
文献标志码:
A
摘要:
目的 研究液基薄层细胞学检测（TCT）、人乳头状瘤病毒（HPV）联合阴道镜检测在早期宫颈癌及癌前病变筛查中的应用价值。方法 回顾分析2019年4月-2021年12月在我院进行宫颈疾病筛查的480例疑似宫颈病变，行TCT和HPV筛查患者的临床资料，其中有453例筛查异常行阴道镜检查。观察TCT、HPV以及TCT+HPV检测阳性率、不同检测方法（TCT+HPV+阴道镜、阴道镜、TCT、HPV）诊断准确率、敏感度和特异度，以及不同检测方法对早期宫颈癌及癌前病变筛查诊断准确率与病理结果的一致性。结果 TCT+HPV检测阳性率均高于TCT、HPV，但TCT与HPV比较，差异无统计学意义（P＞0.05）；TCT+HPV+阴道镜联合诊断准确率均高于TCT、HPV、阴道镜，且阴道镜高于TCT、HPV，HPV高于TCT（P＜0.05）；TCT+HPV+阴道镜检测敏感度、特异度均高于阴道镜、TCT、HPV，且阴道镜高于TCT、HPV，HPV检测敏感度高于TCT检测，TCT检测特异度高于HPV检测（P＜0.05）；TCT+HPV+阴道镜对早期宫颈癌及癌前病变筛查诊断准确率与病理结果具有高度一致性，且一致性高于TCT、HPV以及阴道镜检测（P＜0.05）。结论 TCT、HPV联合阴道镜检测在早期宫颈癌及癌前病变筛查中具有重要的价值，可提高诊断准确性，有效预防漏诊和误诊，可为早期治疗和预防宫颈癌提供可靠的参考依据。
Abstract:
Objective To study the application value of thinprep cytologic test (TCT), human papillomavirus (HPV) combined with colposcopy in the screening of early-stage cervical cancer and precancerous lesions.Methods The clinical data of 480 patients with suspected cervical lesions who underwent TCT and HPV screening in our hospital from April 2019 to December 2021 were retrospectively analyzed. Among them, 453 patients with abnormal screening underwent colposcopy. The positive rates of TCT, HPV and TCT+HPV detection, the diagnostic accuracy, sensitivity and specificity of different detection methods (TCT+HPV+colposcopy, colposcopy, TCT, HPV), and the consistency between the diagnostic accuracy and pathological results of different detection methods for early-stage cervical cancer and precancerous lesions were observed.Results The positive rate of TCT+HPV was higher than that of TCT and HPV, but there was no significant difference between TCT and HPV (P>0.05). The diagnostic accuracy of TCT+HPV+colposcopy was higher than that of TCT, HPV and colposcopy, and colposcopy was higher than TCT and HPV, HPV was higher than TCT (P<0.05). The sensitivity and specificity of TCT+HPV+colposcopy were higher than those of colposcopy, TCT and HPV, and colposcopy was higher than TCT and HPV, while the sensitivity of HPV detection was higher than that of TCT detection, and the specificity of TCT detection was higher than that of HPV detection (P<0.05). The accuracy of TCT+HPV+colposcopy in the screening and diagnosis of early cervical cancer and precancerous lesions was highly consistent with the pathological results, and the consistency was higher than that of TCT, HPV and colposcopy (P<0.05).Conclusion TCT, HPV combined with colposcopy have important value in the screening of early-stage cervical cancer and precancerous lesions, which can improve the diagnostic accuracy, effectively prevent missed diagnosis and misdiagnosis, and provide reliable reference for early treatment and prevention of cervical cancer.

参考文献/References:

[1]李琪.液基细胞学、阴道镜组织活检和HPV-DNA检测防治宫颈癌前病变的价值研究[J].中国妇幼保健,2018,33(15):223-225.[2]李文艳.分析HPV、TCT联合阴道镜检测在早期宫颈病变筛查中的意义[J].泰山医学院学报,2017,38(8):874-875.[3]赵洪伟,张瑜,朱前勇.长链非编码RNASNHG16对人宫颈癌细胞SiHa迁移侵袭的影响[J].新乡医学院学报,2020,37(12):1101-1107.[4]李彦伟.人乳头瘤病毒联合液基细胞学检测在宫颈癌前病变筛查中的临床应用[J].山西医药杂志,2018,47(14):1677-1679.[5]钟彩香.HPV、TCT检测联合电子阴道镜下宫颈活检在宫颈癌前病变及宫颈癌中的诊断价值[J].福建医药杂志,2018,40(5):54-56.[6]魏丽惠,沈丹华,赵方辉,等.中国子宫颈癌筛查及异常管理相关问题专家共识(二)[J].中国妇产科临床杂志,2017,18(3):286-288.[7]张莉.宫颈液基细胞与阴道镜下组织病理检测以及PD-L1在宫颈病变组织表达的临床意义[D].苏州:苏州大学,2018.[8]Saslow D,Andrews KS,Manassaram BD,et al.Human papillomavirus vaccination guideline update:American cancer society guideline endorsement[J].Ca A Cancer Journal for Clinicians,2017,66(5):375-385.[9]陈晓霞.TCT与 HPV-DNA联合检测在宫颈病变中的诊断价值[J].检验医学与临床,2017,14(6):835-836.[10]樊瑛,曾维曦.HPV、TCT联合阴道镜筛查早期宫颈癌的临床意义[J].深圳中西医结合杂志,2019,15(6):71-73.[11]罗晶,李婷婷,王倩,等.液基薄层细胞学检测、人乳头状瘤病毒检测及阴道镜检测在宫颈癌前病变及宫颈癌筛查中的应用价值[J].新乡医学院学报,2021,5(5):140-143.[12]吴瑛,孔晶,吴江平.无明确诊断意义的不典型鳞状细胞患者诊断[J].临床与病理杂志,2018,38(9):1853-1856.[13]卜琦.TCT、HPV联合阴道镜检测在宫颈癌前病变筛查中的诊断价值[J].继续医学教育,2021,31(1):203-205.[14]米兰,颛佳,张岱,等.阴道镜下宫颈管搔刮术对宫颈高级别病变检出的作用[J].中国妇产科临床杂志,2019,20(2):128-131.[15]World Health Organization.Human papillomavirus vaccines: WHO position paper, May 2017[J].Wkly Epidemiol Rec,2017,92(19):241-268.[16]陈飞,李舒,郎景和,等.2017年美国阴道镜和子宫颈病理学会阴道镜检测标准解读[J].中国实用妇科与产科杂志,2018,34(4):413-418.[17]吴秀琼.阴道镜在宫颈癌筛查中的应用[J].医学理论与实践,2020,25(4):131-134.[18]芦亚萍.三阶梯诊断法在宫颈癌筛查诊治中的应用效果[J].实用医技杂志,2019,26(8):1066-1067.[19]孙运明.液基薄层细胞学检测、人乳头瘤病毒及阴道镜检测在宫颈癌患者筛查诊断中的临床价值[J].中国妇幼保健,2019,11(1):126-128.

相似文献/References:

[1]聂小凤,翟慧慧,冷天艳,等.宫颈脱落细胞miR34a检测在HR-HPV阳性患者 分流中的作用分析[J].医学信息,2018,31(16):43.[doi:10.3969/j.issn.1006-1959.2018.16.012]
　NIE Xiao-feng,ZHAI Hui-hui,LENG Tian-yan,et al.Analysis of the Role of MiR34a in Cervical Exfoliated Cells in Shunt of HR-HPV Positive Patients[J].Journal of Medical Information,2018,31(13):43.[doi:10.3969/j.issn.1006-1959.2018.16.012]
[2]邬素珍,许焕英.宫颈人乳头瘤病毒感染的免疫研究进展[J].医学信息,2018,31(19):33.[doi:10.3969/j.issn.1006-1959.2018.19.012]
　WU Su-zhen,XU Huan-ying.Progress in Immunization of Cervical Human Papillomavirus Infection[J].Journal of Medical Information,2018,31(13):33.[doi:10.3969/j.issn.1006-1959.2018.19.012]
[3]祝亚军.高危型HPV-DNA及TCT检测筛查宫颈癌及宫颈癌前病变的价值[J].医学信息,2019,32(22):157.[doi:10.3969/j.issn.1006-1959.2019.22.054]
　ZHU Ya-jun.The Value of Screening High-Risk HPV-DNA and TCT for Cervical Carcinoma and Cervical Precancerous Lesions[J].Journal of Medical Information,2019,32(13):157.[doi:10.3969/j.issn.1006-1959.2019.22.054]
[4]刘琳琳,宫 正,杨海嵘,等.宫颈癌的诊治及预防研究[J].医学信息,2021,34(03):49.[doi:10.3969/j.issn.1006-1959.2021.03.015]
　LIU Lin-lin,GONG Zheng,YANG Hai-rong,et al.Research on Diagnosis,Treatment and Prevention of Cervical Cancer[J].Journal of Medical Information,2021,34(13):49.[doi:10.3969/j.issn.1006-1959.2021.03.015]
[5]刘洪波,祁晓莉,乔 星,等.HPV分型检测联合TCT检查在宫颈病变筛查中的应用[J].医学信息,2018,31(08):152.[doi:10.3969/j.issn.1006-1959.2018.08.053]
　LIU Hong-bo,QI Xiao-li,QIAO Xing,et al.Application of HPV Typing Test Combined with TCT Examination in Screening Cervical Lesions[J].Journal of Medical Information,2018,31(13):152.[doi:10.3969/j.issn.1006-1959.2018.08.053]
[6]朱 军,张振君.妇女宫颈病变筛查分析[J].医学信息,2019,32(01):139.[doi:10.3969/j.issn.1006-1959.2019.01.043]
　ZHU Jun,ZHANG Zhen-jun.Screening Analysis of Cervical Lesions in Women[J].Journal of Medical Information,2019,32(13):139.[doi:10.3969/j.issn.1006-1959.2019.01.043]
[7]邵景萍.HPV联合TCT检测在宫颈疾病筛查中的应用[J].医学信息,2022,35(10):168.[doi:10.3969/j.issn.1006-1959.2022.10.043]
　SHAO Jing-ping.Application of HPV Combined with TCT in Cervical Disease Screening[J].Journal of Medical Information,2022,35(13):168.[doi:10.3969/j.issn.1006-1959.2022.10.043]
[8]见永康,吴泽俊,庄雅丽.宫颈癌筛查联合阴道镜活检防治宫颈癌前病变的价值研究[J].医学信息,2023,36(16):117.[doi:10.3969/j.issn.1006-1959.2023.16.022]
　JIAN Yong-kang,WU Ze-jun,ZHUANG Ya-li.Study on the Value of Cervical Cancer Screening Combined with Colposcopy Biopsy in the Prevention and Treatment of Cervical Precancerous Lesions[J].Journal of Medical Information,2023,36(13):117.[doi:10.3969/j.issn.1006-1959.2023.16.022]
[9]王 意,李子珊,雷 雯,等.HPV E6/E7 mRNA检测对HPV16/18 DNA阳性患者的分流价值[J].医学信息,2024,37(18):57.[doi:10.3969/j.issn.1006-1959.2024.18.010]
　WANG Yi,LI Zi-shan,LEI Wen,et al.Shunt Value of HPV E6/E7 mRNA Detection in HPV16/18 DNA Positive Patients[J].Journal of Medical Information,2024,37(13):57.[doi:10.3969/j.issn.1006-1959.2024.18.010]

更新日期/Last Update: 1900-01-01